Search the Newsreel

Baltic Classifieds (LSE:BCG) Shows Why Local Digital Markets Can Still Grow

OR Royalties Inc. 2026 Q2 - Results - Earnings Call Presentation (TSX:OR:CA) 2026-08-06

Why OR Royalties (TSX:OR) Is Up 8.9% After Revenue Surges on New Royalty Acquisitions

OR Royalties Inc. recently announced that its Board approved a third-quarter 2026 dividend of US$0.065 per share, payable on October 15, 2026 to shareholders of record on September 30, 2026, and highlighted its dividend reinvestment plan offering a 3% discount. The company also reported …

OR Royalties Declares Third Quarter 2026 Dividend

OR Royalties Inc. MONTRÉAL, Aug. 05, 2026 (GLOBE NEWSWIRE) -- OR Royalties Inc. ("OR Royalties" or the "Company") (OR: TSX & NYSE) is pleased to announce that the Company's Board of Directors has approved a third quarter 2026 dividend of US$0.065 per common share. …

OR Royalties Reports 62% Year-Over-Year Increase in Revenues and Cash Flows from Operations in Q2 2026 and Continued Share Repurchases Under the Normal Course Issuer Bid

OR Royalties Inc. MONTRÉAL, Aug. 05, 2026 (GLOBE NEWSWIRE) -- OR Royalties Inc. ("OR Royalties" or the "Company") (OR: TSX & NYSE) today announced its consolidated financial results for the second quarter of 2026. Quarterly revenues grew 62% year-over-year on a 5% increase in …

Altimmune to discuss its liver-treatment candidate Aug. 12

Altimmune (Nasdaq: ALT) will report its second quarter 2026 financial results on Wednesday, August 12, 2026, including a conference call and webcast at 8:30 a.m. ET to review results and provide a business update. The company is a late clinical-stage biopharmaceutical company developing pemvidutide …

Altimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026

Altimmune, Inc. (Nasdaq: ALT) announced it will report its second quarter 2026 financial results and provide a business update on Wednesday, August 12, 2026. Management will host a conference call at 8:30 a.m. ET to discuss the results and update, which will also be …

Deterra Royalties (ASX:DRR) Dividend Review: A 5.89% Yield from a Mining Royalties Business

Altisource Portfolio Solutions (NASDAQ:ASPS) Major Shareholder Benefit Street Partners Llc Purchases 48,991 Shares of Stock

Benefit Street Partners Llc, a major shareholder in Altisource Portfolio Solutions (NASDAQ:ASPS), recently increased its stake by purchasing 48,991 shares for approximately $283,168. This transaction brings their total ownership to 1,803,045 shares. The purchase occurred as ASPS shares traded down to $5.25, below its …

Benefit Street Partners acquires $288,728 of Altisource Portfolio Solutions common shares

Benefit Street Partners, a 10% owner of Altisource Portfolio Solutions, increased its stake in the company by acquiring $288,728 worth of common shares through open-market purchases. This acquisition raised their total holdings to 1,803,045 common shares, with purchases made at weighted average prices of …

VMET|Versamet Royalties Ord Shs|Price:9.210|Chg%:+0.380

Altimmune (ALT) Projected to Release Quarterly Earnings on Tuesday

ECOR Looks 32.3% Undervalued on GF Value™ Amid Price-to-Sales Co

Freehold Royalties Signals Momentum in Earnings Call

Key Points Interested in Freehold Royalties Ltd.? Here are five stocks we like better. Strong quarterly results: Freehold Royalties reported C$78 million in Q2 funds from operations, up 30% sequentially, as higher commodity prices lifted revenue. The company returned C$44 million to shareholders through …

Altimmune (ALT) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $ALT

This article provides a comprehensive overview of Altimmune's FDA-related activities for its drug pemvidutide, detailing clinical trial updates, regulatory submissions, and designations through 2026. Pemvidutide is being developed for conditions including obesity, MASH (metabolic dysfunction-associated steatohepatitis),

Altimmune (ALT) CFO acquires 1,753 shares via employee stock purchase plan

Altimmune, Inc. (ALT) CFO Gregory L. Weaver acquired 1,753 shares of common stock on July 31, 2026, through the company's 2019 Employee Stock Purchase Plan (ESPP). The shares were purchased at $2.414 each, representing 85% of the closing price on that day, for the …

Altitude Group plc Reports Earnings Results for the Full Year Ended March 31, 2026

Versamet Royalties Corp. Revenue Breakdown – TSX:VMET

Versamet Royalties Corp. (TSX: VMET) reported a total revenue of 47.74 million CAD last year. The Gold segment was the highest performing, generating 33.51 million CAD, an increase from 13.68 million CAD in the previous year. Canada was the primary regional contributor, accounting for …

Altitude Group reports top-end revenue but passes on dividend payment

Altimmune Initiates PERFORMA Phase 3 Trial Of Pemvidutide In Patients With Mash

Altimmune has announced the initiation of its PERFORMA Phase 3 trial for pemvidutide. This trial focuses on evaluating the drug's efficacy in patients diagnosed with MASH (Metabolic Dysfunction-Associated Steatohepatitis). The information was released via Reuters and is available on TradingView.

Altitude Group plc (ALT) Reports 19% Revenue Increase to $44.4M for FY Ending 31 March 2026 and Unveils AI-Driven AIM iQ™ Platform

AlTi Global (ALTI) Expected to Announce Quarterly Earnings on Monday

Earnings Flash (ALT.L) Altitude Group Posts FY26 Loss $0.003

Altitude pivots to high-margin tech as restructuring nudges FY26 into loss

TNR Gold nears first royalty payment from Mariana lithium project - ICYMI

TNR Gold nears first royalty payment from Mariana lithium project - ICYMI Proactive uses images sourced from Shutterstock TNR Gold Corp (TSX-V:TNR, FRA:TNW, OTC:TRRXF) executive chairman Kirill Klip talked with Proactive about the company's latest milestones, highlighting increased institutional backing from Altius Minerals, progress …

Form 4 ALTISOURCE PORTFOLIO SOLUTIONS S.A. For: 31 July By Investing.com

This article announces the filing of Form 4 for Altisource Portfolio Solutions S.A. (ASPS) for transactions made on July 31. It is a brief administrative notice from Investing.com, providing basic information without detailed analysis. The page also includes various market data and other news …

Altitude Group plc Revenue Breakdown – LSE:ALT

Altius Minerals Corporation Revenue Breakdown – TSX:ALS

Earnings Jump On Lower Volumes Might Change The Case For Investing In Freehold Royalties (TSX:FRU)

Vanguard Capital Management (ASPS) discloses 5.07% Altisource beneficial stake via warrants

Vanguard Capital Management, along with its affiliates, has reported a 5.07% beneficial stake in Altisource Portfolio Solutions, amounting to 571,991.9467 common stock equivalents, primarily in the form of warrants. The filing, a SCHEDULE 13G, indicates Vanguard has sole voting power over 73,290.38 shares and …

Freehold Royalties Ltd's Dividend Analysis

This article first appeared on GuruFocus. Assessing the Sustainability and Growth of Freehold Royalties Ltd's Monthly Payouts Freehold Royalties Ltd (FRHLF) recently announced a total dividend of $0.06 per share, with the ex-dividend date set for 2026-08-31. This includes a $0.06 per share cash …

Baltic Classifieds Group Plc Revenue Breakdown – LSE:BCG

Altimmune Inc Today's Market Trends | ALT Stock Real-Time Quotes, Trading Strategies & Related Analysis | TradingKey

This article provides a detailed analysis of Altimmune Inc (ALT) stock, highlighting its market trends, real-time quotes, and trading strategies. It covers key financial figures, institutional ownership, analyst ratings, and the company's biopharmaceutical pipeline, including pemvidutide for obesity and MASH. Despite recent stock performance, …

What's Going On With Freehold Royalties Ltd. Stock Thursday?

Freehold Royalties Ltd (FRHLF) (Q2 2026) Earnings Call Highlights: Record Revenue and FFO ...

This article first appeared on GuruFocus. Revenue: Q2 royalty and other revenue totaled $100 million, up 29% compared to Q1 2026. Funds from Operations (FFO): $78 million, or $0.47 per share, up 30% from Q1 2026. Average Realized Price: $69 per BOE, compared with …

Altius Minerals Corporation Closes Transaction Increasing Ownership Interest in Great Bay Renewables and Announces Increased Credit Facility

ST. JOHN'S, Newfoundland and Labrador, July 30, 2026--(BUSINESS WIRE)--Altius Minerals Corporation (TSX: ALS) (OTCQX: ATUSF) ("Altius") is pleased to announce the successful closing of the transaction, originally announced on July 10, 2026, to increase its effective ownership interest in Great Bay Renewable Holdings, LLC …